These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38134944)

  • 1. Diagnostic yield of a proactive strategy for early detection of cardiovascular disease versus usual care in adults with type 2 diabetes or chronic obstructive pulmonary disease in primary care in the Netherlands (RED-CVD): a multicentre, pragmatic, cluster-randomised, controlled trial.
    Groenewegen A; Zwartkruis VW; Rienstra M; Zuithoff NPA; Hollander M; Koffijberg H; Oude Wolcherink M; Cramer MJ; van der Schouw YT; Hoes AW; Rutten FH; de Boer RA
    Lancet Public Health; 2024 Feb; 9(2):e88-e99. PubMed ID: 38134944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving early diagnosis of cardiovascular disease in patients with type 2 diabetes and COPD: protocol of the RED-CVD cluster randomised diagnostic trial.
    Groenewegen A; Zwartkruis VW; Rienstra M; Hollander M; Koffijberg H; Cramer MJM; van der Schouw YT; Hoes AW; de Boer RA; Rutten FH
    BMJ Open; 2021 Oct; 11(10):e046330. PubMed ID: 34702727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial.
    Uittenbogaart SB; Verbiest-van Gurp N; Lucassen WAM; Winkens B; Nielen M; Erkens PMG; Knottnerus JA; van Weert HCPM; Stoffers HEJH
    BMJ; 2020 Sep; 370():m3208. PubMed ID: 32938633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a family-based cardiovascular risk reduction intervention in individuals with a family history of premature coronary heart disease in India (PROLIFIC): an open-label, single-centre, cluster randomised controlled trial.
    Jeemon P; Harikrishnan S; Ganapathi S; Sivasankaran S; Binukumar B; Padmanabhan S; Tandon N; Prabhakaran D
    Lancet Glob Health; 2021 Oct; 9(10):e1442-e1450. PubMed ID: 34534488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial.
    Jensen M; Suling A; Metzner A; Schnabel RB; Borof K; Goette A; Haeusler KG; Zapf A; Wegscheider K; Fabritz L; Diener HC; Thomalla G; Kirchhof P
    Lancet Neurol; 2023 Jan; 22(1):45-54. PubMed ID: 36517170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.
    Francis NA; Gillespie D; White P; Bates J; Lowe R; Sewell B; Phillips R; Stanton H; Kirby N; Wootton M; Thomas-Jones E; Hood K; Llor C; Cals J; Melbye H; Naik G; Gal M; Fitzsimmons D; Alam MF; Riga E; Cochrane A; Butler CC
    Health Technol Assess; 2020 Mar; 24(15):1-108. PubMed ID: 32202490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial.
    Kruis AL; Boland MR; Assendelft WJ; Gussekloo J; Tsiachristas A; Stijnen T; Blom C; Sont JK; Rutten-van Mölken MP; Chavannes NH
    BMJ; 2014 Sep; 349():g5392. PubMed ID: 25209620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial.
    Griffin SJ; Rutten GEHM; Khunti K; Witte DR; Lauritzen T; Sharp SJ; Dalsgaard EM; Davies MJ; Irving GJ; Vos RC; Webb DR; Wareham NJ; Sandbæk A
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):925-937. PubMed ID: 31748169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunistic screening versus usual care for diagnosing atrial fibrillation in general practice: a cluster randomised controlled trial.
    Kaasenbrood F; Hollander M; de Bruijn SH; Dolmans CP; Tieleman RG; Hoes AW; Rutten FH
    Br J Gen Pract; 2020 Jun; 70(695):e427-e433. PubMed ID: 31988084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): a cluster-randomised controlled trial.
    Jordan RE; Adab P; Sitch A; Enocson A; Blissett D; Jowett S; Marsh J; Riley RD; Miller MR; Cooper BG; Turner AM; Jolly K; Ayres JG; Haroon S; Stockley R; Greenfield S; Siebert S; Daley AJ; Cheng KK; Fitzmaurice D
    Lancet Respir Med; 2016 Sep; 4(9):720-730. PubMed ID: 27444687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the Assessment of Burden of Chronic Conditions (ABCC)-tool in patients with asthma, COPD, type 2 diabetes mellitus, and heart failure: A pragmatic clustered quasi-experimental study in the Netherlands.
    Boudewijns EA; Claessens D; van Schayck OCP; Twellaar M; Winkens B; Joore MA; Keijsers LCEM; Krol S; Urlings M; Gidding-Slok AHM
    Eur J Gen Pract; 2024 Dec; 30(1):2343364. PubMed ID: 38738695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proactive screening for symptoms: A simple method to improve early detection of unrecognized cardiovascular disease in primary care. Results from the Lifelines Cohort Study.
    Zwartkruis VW; Groenewegen A; Rutten FH; Hollander M; Hoes AW; van der Ende MY; van der Harst P; Cramer MJ; van der Schouw YT; Koffijberg H; Rienstra M; de Boer RA
    Prev Med; 2020 Sep; 138():106143. PubMed ID: 32473262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial.
    Inzucchi SE; Claggett BL; Vaduganathan M; Desai AS; Jhund PS; de Boer RA; Hernandez AF; Kosiborod MN; Lam CSP; Martinez F; Shah SJ; Verma S; Han Y; Kerr Saraiva JF; Bengtsson O; Petersson M; Langkilde AM; McMurray JJV; Solomon SD
    Lancet Diabetes Endocrinol; 2022 Dec; 10(12):869-881. PubMed ID: 36372069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial.
    Bischoff EW; Akkermans R; Bourbeau J; van Weel C; Vercoulen JH; Schermer TR
    BMJ; 2012 Nov; 345():e7642. PubMed ID: 23190905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): a cluster randomized trial.
    van Riet EE; Hoes AW; Limburg A; van der Hoeven H; Landman MA; Rutten FH
    BMC Cardiovasc Disord; 2014 Jan; 14():1. PubMed ID: 24400643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting and Diagnosing Atrial Fibrillation (D2AF): study protocol for a cluster randomised controlled trial.
    Uittenbogaart SB; Verbiest-van Gurp N; Erkens PM; Lucassen WA; Knottnerus JA; Winkens B; van Weert HC; Stoffers HE
    Trials; 2015 Oct; 16():478. PubMed ID: 26499449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial.
    Mackenzie IS; Hawkey CJ; Ford I; Greenlaw N; Pigazzani F; Rogers A; Struthers AD; Begg AG; Wei L; Avery AJ; Taggar JS; Walker A; Duce SL; Barr RJ; Dumbleton JS; Rooke ED; Townend JN; Ritchie LD; MacDonald TM;
    Lancet; 2022 Oct; 400(10359):1195-1205. PubMed ID: 36216006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
    Fitzgerald RC; di Pietro M; O'Donovan M; Maroni R; Muldrew B; Debiram-Beecham I; Gehrung M; Offman J; Tripathi M; Smith SG; Aigret B; Walter FM; Rubin G; ; Sasieni P
    Lancet; 2020 Aug; 396(10247):333-344. PubMed ID: 32738955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial.
    Svendsen JH; Diederichsen SZ; Højberg S; Krieger DW; Graff C; Kronborg C; Olesen MS; Nielsen JB; Holst AG; Brandes A; Haugan KJ; Køber L
    Lancet; 2021 Oct; 398(10310):1507-1516. PubMed ID: 34469766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.